ReviewBMC infectious diseases2025
Recurrent knee septic arthritis and osteomyelitis due to Candida viswanathii: a case report and literature review.
Review in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Yeast in the Vial: IatrogenicJournal of fungi (Basel, Switzerland) · 2026Article
- Multicentre outbreak ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Article
- UnmaskingPathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCandida viswanathii is a rare Candida with fewer than 40 clinical cases of infection reported globally and with limited treatment descriptions available. Here we report a rare case of recurrent candida septic arthritis and osteomyelitis caused by C. viswanathii. CASE PRESENTATION: A 78-year-old Chinese female developed her first episode of C. viswanathii septic arthritis and osteomyelitis likely following intra-articular lignocaine injections to her left knee. She was treated with 2 surgical washouts and 16 months of antifungal agents, which included an initial 6 months of voriconazole followed by fluconazole, with full recovery. However, she presents with recurrence of left knee pain 14 months after antifungal therapy was stopped. Open arthrotomy revealed extensive synovitis and granulation tissue, with a sinus tract extending to the anterior patella. C. viswanathii was re-cultured in her synovial fluid and identified via a combination of fungal phenotypic tests and DNA sequencing of the ITS region and the D1/D2 region of the 28 S ribosomal subunit. She was managed with two open knee arthrotomies, drainage with curettage and debridement, and was reinitiated on oral voriconazole therapy, to which she demonstrated a good clinical response. She was subsequently maintained on chronic suppressive oral voriconazole therapy. Her symptoms remain well controlled, and no relapse was observed on the last follow-up. Additionally, we have also done a comprehensive literature review of all the published clinical cases of C. viswanathii thus far.
conclusionThis is the first case report to describe the successful treatment and monitoring of recurrent C. viswanathii osteoarticular infection. Combined with our literature review, we aim to increase understanding of this rare candida species- specifically its clinical trajectory in osteoarthritic infections, laboratory features, radiological characteristics, intra-operative findings, and treatment aspects inclusive of a potential role for long-term suppressive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.